Cargando…

The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)

Since 2001, the Brazilian Ministry of Health has been coordinating a National Neonatal Screening Program (NNSP) that now covers all the 26 states and the Federal District of the Brazilian Republic and targets six diseases including sickle cell disease (SCD) and other hemoglobinopathies. In 2005, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva-Pinto, Ana C., Alencar de Queiroz, Maria Cândida, Antoniazzo Zamaro, Paula Juliana, Arruda, Miranete, Pimentel dos Santos, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510189/ https://www.ncbi.nlm.nih.gov/pubmed/33072971 http://dx.doi.org/10.3390/ijns5010011

Ejemplares similares

Gene deletions of glutathione S-transferase and iron status in sickle cell patients
por: Zamaro, Paula Juliana Antoniazzo
Publicado: (2012)

Comparing electrophoresis at alkaline pH and high performance liquid chromatography to diagnose Hb S-like hemoglobin
por: de Oliveira, Renan Gracia, et al.
Publicado: (2012)

What influences Hb fetal production in adulthood?
por: Carrocini, Gisele Cristine de Souza, et al.
Publicado: (2011)

World Coalition on SCD launches, sparking global focus on SCD diagnosis and care
por: Zapfel, Andrew, et al.
Publicado: (2023)

Pregnancies and Neonatal Outcomes in Patients with Sickle Cell Disease (SCD): Still a (High-)Risk Constellation?
por: Proske, Pia, et al.
Publicado: (2021)

Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation
por: Alashkar, Ferras, et al.
Publicado: (2022)

48847 Assessing Transition Outcomes in Sickle Cell Disease (SCD) Prior To Implementation of A Formal Transition Program
por: Sheppard, Sydney, et al.
Publicado: (2021)

Liver Iron Content (LIC) in Adults with Sickle Cell Disease (SCD): Correlation with Serum Ferritin and Liver Enzymes Concentrations in Trasfusion Dependent (TD-SCD) and Non-Transfusion Dependent (NT-SCD) Patients
por: Yassin, Mohamed, et al.
Publicado: (2017)

Effectiveness of a home-based therapeutic exercise program on lower back pain and functionality in Sickle Cell Disease (SCD) patients
por: Zanoni, Camila Tatiana, et al.
Publicado: (2021)

P-004: HEALTH CARE TRANSITION (HCT) FOR SICKLE CELL DISEASE (SCD) CAN BE STANDARDIZED: RESULTS OF IMPLEMENTING A SCD HCT LEARNING COLLABORATIVE.
por: I., OSUNKWO, et al.
Publicado: (2022)

Effects of home-based inspiratory muscle training on sickle cell disease (SCD) patients
por: Galvão, Fábio, et al.
Publicado: (2021)

P110: CLINICAL CHARACTERISTICS OF COVID-19 IN SICKLE CELL DISEASE (SCD) PATIENTS
por: Malhan, H, et al.
Publicado: (2022)

Moyamoya Syndrome (MMS) in a Patient With Sickle Cell Disease (SCD) and Protein S Deficiency
por: Saxena, Parima, et al.
Publicado: (2023)

Sickle Cell Disease (SCD) Leading to Pulmonary Arterial Hypertension (PAH) and Cholelithiasis (CL)
por: Chacko, Saran, et al.
Publicado: (2023)

Mortality by sickle cell disease in Brazil
por: Arduini, Giovanna Abadia Oliveira, et al.
Publicado: (2017)

Neuropsychological assessment, neuroimaging, and neuropsychiatric evaluation in pediatric and adult patients with sickle cell disease (SCD)
por: Edwards, Christopher L, et al.
Publicado: (2007)

MR-Augmented Cardiopulmonary Exercise Testing- a proof of concept in Sickle Cell Disease (SCD)
por: Ako, Emmanuel O, et al.
Publicado: (2016)

coreSCD: multi-stakeholder consensus on core outcomes for sickle cell disease clinical trials
por: Tambor, Ellen, et al.
Publicado: (2021)

The Sickle Cell Disease Functional Assessment (SCD-FA) tool: a feasibility pilot study
por: Oyedeji, Charity I., et al.
Publicado: (2022)

Radiological manifestation of avascular necrosis (AVN) in sickle cell disease (SCD): a review of diagnostic imaging
por: Mohamed Aziz Bedair, Elsaid, et al.
Publicado: (2023)

Advancements in Sickle Cell Disease (SCD) Treatment: A Review of Novel Pharmacotherapies and Their Impact on Patient Outcomes
por: Khan, Salman J, et al.
Publicado: (2023)

SPATIAL DISTRIBUTION OF NEWBORNS WITH SICKLE CELL TRAIT IN SERGIPE, BRAZIL
por: Leite, Débora Cristina Fontes, et al.
Publicado: (2020)

PB2214: SCD POPULATION SURVEY IN ALBANIA, A PROSPECTIVE NON-INTERVENTIONAL MULTI-CENTER STUDY EVALUATING DISEASE AND PATIENTS CHARACTERISTICS OF SICKLE CELL DISEASE IN ALBANIAN SCD POPULATION
por: Cili, A., et al.
Publicado: (2022)

Routine Paediatric Sickle Cell Disease (SCD) Outpatient Care in a Rural Kenyan Hospital: Utilization and Costs
por: Amendah, Djesika D., et al.
Publicado: (2013)

Heterogeneity of βs gene haplotypes in patients with sickle cell disease (SCD) in Oman: A review of relevant publications
por: Al-Mashaikhi, Nawal, et al.
Publicado: (2022)

Economic burden of sickle cell disease in Brazil
por: Silva-Pinto, Ana Cristina, et al.
Publicado: (2022)

S131: REGIONAL ASSESSMENT OF THE EXPERIENCES OF HEALTHCARE PROFESSIONALS (HCPS) TREATING PATIENTS WITH SICKLE CELL DISEASE (SCD): THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: Osunkwo, I, et al.
Publicado: (2022)

S121: REDUCED RATE OF VASO-OCCLUSIVE CRISES (VOCS) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) TREATED WITH CRIZANLIZUMAB FOR 12 MONTHS: RESULTS FROM A REAL-WORLD, MANAGED ACCESS PROGRAM (MAP)
por: Silva-Pinto, A, et al.
Publicado: (2022)

Metabolic Changes in Skin Caused by Scd1 Deficiency: A Focus on Retinol Metabolism
por: Flowers, Matthew T., et al.
Publicado: (2011)

P1491: REAL-WORLD INCIDENCE OF VASO-OCCLUSIVE CRISES IN PATIENTS WITH SICKLE CELL DISEASE (SCD) AND A HIGH BASELINE DISEASE BURDEN TREATED WITH CRIZANLIZUMAB: RESULTS FROM A MANAGED ACCESS PROGRAM (MAP)
por: Silva-Pinto, A. C., et al.
Publicado: (2022)

P1480: SPLENIC SEQUESTRATION IS MORE COMMON IN SCD-S/Β0-THAL THAN IN SCD-S/S PATIENTS: RESULTS FROM THE GERMAN SCD REGISTRY
por: Allard, P., et al.
Publicado: (2022)

P-010: TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HEALTHCARE PROFESSIONAL (HCP)–PATIENT RELATIONSHIP: HCP OPINIONS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: B., ANDEMARIAM, et al.
Publicado: (2022)

Clinical findings associated with homozygous sickle cell disease in the Barbadian population – do we need a national SCD registry?
por: Quimby, Kim R, et al.
Publicado: (2014)

Identification of therapeutic targets for inflammation in sickle cell disease (SCD) among Indian patients using gene expression data analysis
por: Das, Ipsita, et al.
Publicado: (2018)

438 “How do you define Resilience?” Examining the Psychological Resilience of Black Adults Living with Sickle Cell Disease (SCD)
por: Conn, Corinne April Iolanda, et al.
Publicado: (2022)

Clinical and epidemiological features and therapeutic options of avascular necrosis in patients with sickle cell disease (SCD): A cross-sectional study
por: Alshurafa, Awni, et al.
Publicado: (2023)

Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30
por: Pelser, Colleen, et al.
Publicado: (2010)

The sickle cell trait and end stage renal disease in Salvador, Brazil
por: Alladagbin, Dona J., et al.
Publicado: (2018)

P1467: HEALTHCARE PROFESSIONALS (HCP) OPINIONS ON TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HCP–PATIENT RELATIONSHIP: RESULTS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: Andemariam, B., et al.
Publicado: (2022)

Sickle Cell Disease (SCD) As a Risk for COVI19 Compared to Those without SCD Among Patients Admitted in a Large Urban Center, As Estimated By PCR Sars-v-2 Positive Vs Negative Testing
por: Adamkiewicz, Tom, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kh3n7q9bctrsppbqkcsa84fehs